Comment
doi: 10.1111/apt.15324.
Letter: mechanistic target of rapamycin inhibitors-do they impact on recurrence of hepatocellular carcinoma after liver transplantation? Authors' reply
Affiliations
- PMID: 31184392
- DOI: 10.1111/apt.15324
Item in Clipboard
Comment
Letter: mechanistic target of rapamycin inhibitors-do they impact on recurrence of hepatocellular carcinoma after liver transplantation? Authors' reply
Aliment Pharmacol Ther.
2019 Jul.
No abstract available
Comment on
-
Systematic review with meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.Aliment Pharmacol Ther. 2019 May;49(10):1260-1273. doi: 10.1111/apt.15253. Epub 2019 Apr 15. Aliment Pharmacol Ther. 2019. PMID: 30989721
-
Letter: mechanistic target of rapamycin inhibitors-do they impact on recurrence of hepatocellular carcinoma after liver transplantation?Aliment Pharmacol Ther. 2019 Jul;50(1):116-117. doi: 10.1111/apt.15310. Aliment Pharmacol Ther. 2019. PMID: 31184384 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical